iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.
Basic Details
Issuer BlackRock
Fund NameiShares Nasdaq Biotechnology ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:IBB
Inception Date2/5/2001
Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
WebN/A
PhoneN/A
Fund Focus
Asset ClassEquity
BenchmarkNASDAQ Biotechnology TR USD
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America
Fund Statistics
Assets Under Management$8.91 billion
Average Daily Volume$2.56 million
Discount/Premium-4.38%
ETF Expenses
Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%
Administrator, Advisor and Custodian
AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial
iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions
What is iShares Nasdaq Biotechnology ETF's stock symbol?
iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."
How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF?
iShares Nasdaq Biotechnology ETF announced a quarterly dividend on Thursday, September 27th. Shareholders of record on Thursday, September 27th will be paid a dividend of $0.0324 per share on Tuesday, October 2nd. This represents a $0.13 annualized dividend and a yield of 0.12%. The ex-dividend date of this dividend is Wednesday, September 26th. View iShares Nasdaq Biotechnology ETF's Dividend History.
When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work?
iShares Nasdaq Biotechnology ETF's stock split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split.
Has iShares Nasdaq Biotechnology ETF been receiving favorable news coverage?
Media headlines about IBB stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave media headlines about the financial services provider a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the company's share price in the next several days.
Who are some of iShares Nasdaq Biotechnology ETF's key competitors?
Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Gabelli Equity Trust (GAB), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Tortoise Energy Infrastructure (TYG), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Hercules Capital (HTGC), PIMCO High Income Fund (PHK), Boulder Growth & Income Fund (BIF), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF) and Solar Capital (SLRC).
What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own?
Who are iShares Nasdaq Biotechnology ETF's key executives?
iShares Nasdaq Biotechnology ETF's management team includes the folowing people:
- George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
- Michael Arthur Latham, President, Trustee
- Jack Gee, Chief Financial Officer, Treasurer
- Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
- , Bio & Compensation -
- Amy Schioldager, Executive Vice President
- Ira P. Shapiro, Vice President, Chief Legal Officer
- Matt Tucker, Vice President
- , Bio & Compensation -
- Eilleen M. Clavere, Secretary
- Cecilia H. Herbert, Independent Trustee
- Charles A. Hurty, Independent Trustee
Who are iShares Nasdaq Biotechnology ETF's major shareholders?
iShares Nasdaq Biotechnology ETF's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Bank of America Corp DE (17.68%), PNC Financial Services Group Inc. (0.83%), LPL Financial LLC (0.63%), State of Tennessee Treasury Department (0.57%), Lockheed Martin Investment Management Co. (0.56%) and Main Management LLC (0.53%).
Which institutional investors are selling iShares Nasdaq Biotechnology ETF stock?
IBB stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Commerzbank Aktiengesellschaft FI, Two Sigma Investments LP, Aviance Capital Management LLC, Private Management Group Inc., Vigilant Capital Management LLC, Raymond James & Associates and PNC Financial Services Group Inc..
Which institutional investors are buying iShares Nasdaq Biotechnology ETF stock?
IBB stock was acquired by a variety of institutional investors in the last quarter, including State of Tennessee Treasury Department, Lockheed Martin Investment Management Co., Tibra Equities Europe Ltd, Two Sigma Advisers LP, Baker Avenue Asset Management LP, Ferguson Wellman Capital Management Inc., Bank of Montreal Can and Casdin Capital LLC.
How do I buy shares of iShares Nasdaq Biotechnology ETF?
Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is iShares Nasdaq Biotechnology ETF's stock price today?
One share of IBB stock can currently be purchased for approximately $108.17.
How big of a company is iShares Nasdaq Biotechnology ETF?
iShares Nasdaq Biotechnology ETF has a market capitalization of $8.11 billion.
MarketBeat Community Rating for iShares Nasdaq Biotechnology ETF (NASDAQ IBB)
MarketBeat's community ratings are surveys of what our community members think about iShares Nasdaq Biotechnology ETF and other stocks. Vote "Outperform" if you believe IBB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBB will underperform the S&P 500 over the long term. You may vote once every thirty days.
